A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population
Clinical trial NCT06385158 · COMPLETED
Trial details
- NCT number
- NCT06385158
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2024-01-06
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.